Table 4 Various rates of TRM in ALL and AML in both HICs and LICs
From: Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador
Reference | Protocol | HIC vs LIC | Country | TRM (%) |
|---|---|---|---|---|
ALL | ||||
NOPHO ALL92 | HIC | Nordic | 3.0 | |
DCOG ALL-6, 7 and 8 | HIC | The Netherlands | 2.1 | |
Total Therapy XI-XIV | HIC | United States | 2.9 | |
HKALL 93 | HIC | Hong Kong | 2.8 | |
MRCUKALLX | HIC | United Kingdom | 5.6 | |
Gupta S et al (current) | St. Jude's Modified | LIC | El Salvador | 12.5 |
Total XI, Total XIII | LIC | Brazil | 14.9 | |
St. Jude's Modified | LIC | Honduras | 20.8 | |
Modified CCSG | LIC | Thailand | 11.5 | |
MCP841 | LIC | India | 16.0 | |
Modified BFM | LIC | Pakistan | 14.3 | |
AML | ||||
AML-BFM 98 | HIC | Various | 7.2 | |
POG 8821 | HIC | Various | 14.4 | |
DCOG AML-82, 87 and 92/94 | HIC | Netherlands | 16.6 | |
AML-BFM 93 | HIC | Various | 9.7 | |
AML-83, 87, 91, 97 | HIC | United States | 7.6 | |
UKMRC AML10 | HIC | Various | 13.8 | |
Gupta S et al (current) | Modified BFM93 | LIC | El Salvador | 33.1 |
PPLLSG 98 | LIC | Poland | 18.0 | |